l‐carnitine and cancer cachexia: Clinical and experimental aspects

Puccio M, 1997, The cancer cachexia syndrome, Semin Oncol, 24, 277

Nelson KA, 2000, The cancer anorexia–cachexia syndrome, Semin Oncol, 27, 64

10.1007/s005200050282

10.1016/S0960-7404(99)00045-6

10.1007/s13539-010-0002-6

Argilés JM, 1997, The metabolic basis of cancer cachexia, Med Res Ver, 17, 477

10.1007/s13539-010-0014-2

10.1002/med.2610120605

10.1152/physrev.00016.2008

10.1097/MCO.0b013e32831cef61

10.1093/ajcn/83.4.735

Pajak B, 2008, Crossroads of cytokine signaling—the chase to stop muscle cachexia, J Physiol Pharmacol, 59, 251

10.1055/s-2007-978617

10.1152/physrev.1983.63.4.1420

10.1016/0026-0495(91)90033-S

Mitwalli AH, 2005, L-carnitine supplementation in hemodialysis patients, Saudi J Kidney Dis Transplant, 16, 17

Visarius TN, 1999, Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats, J Pharmacol Exp Ther, 289, 820

10.1158/1078-0432.CCR-10-1239

10.1001/archpedi.1987.04460060076039

10.1080/07315724.1989.10720288

10.1038/sj.bjc.6600413

10.1196/annals.1320.016

10.1016/j.ejim.2005.02.014

10.3748/wjg.v12.i28.4541

10.1097/MPH.0b013e3181b259a7

10.2174/1389201033489829

10.1097/01.mco.0000232905.89662.60

10.1038/bjc.1995.482

Li Y-P, 2001, TNF-α regulates early differentiation of C2C12 myoblasts in an autocrine fashion, FASEB J, 15, 1413, 10.1096/fj.00-0632fje

10.1006/bbrc.2000.2462

10.1016/j.clnu.2007.06.005

Nakashima J, 1998, Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer, Clin Cancer Res, 4, 1743

Karayiannakis AJ, 2001, Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients, Anticancer Res, 21, 1335

10.1084/jem.167.3.1211

10.1007/BF00926829

10.1038/bjc.1993.4

10.1096/fasebj.12.10.971

10.1006/jmcc.2001.1453

10.1007/s100720050062

Figueras M, 2005, Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue, Int J Oncol, 27, 855

10.1152/ajpendo.90529.2008

10.1093/ajcn/72.2.618S

10.1159/000185912

10.1038/ki.1994.460

10.1002/ijc.10143

10.1615/JEnvPathToxOncol.v22.i1.20

10.1007/s001090100234

10.1097/MCO.0b013e328122db94

10.1097/00005768-200103000-00006

10.1016/j.febslet.2005.02.017

10.1016/S0304-3835(02)00006-X

Murr C, 1999, Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?, Anticancer Res, 19, 1721

10.1016/j.nbd.2005.11.002

10.1152/japplphysiol.01202.2006

10.1054/bjoc.1999.0933

Ushmorov A, 1999, Differential reconstitution of mitochondrial respiratory chain activity and plasma redox state by cysteine and ornithine in a model of cancer cachexia, Cancer Res, 59, 3527

10.1096/fasebj.10.10.8751725

10.1016/j.nut.2005.06.003

Fatouros IG Douroudos I Panagoutsos S Pasadakis P Nikolaidis MG Chatzinikolaou A Sovatzidis A Michailidis Y Jamurtas AZ Mandalidis D Taxildaris K Vargemezis V. L-carnitine Effects on Oxidative Stress Responses in Patients With Renal Disease. Med Sci Sports Exerc 2010 [Epub ahead of print].

10.1007/s10571-008-9313-y

Malaguarnera M Gargante MP Russo C Antic T Vacante M Malaguarnera M Avitabile T Li Volti G Galvano F. L-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis-A Randomized and Controlled Clinical Trial. Am J Gastroenterol. 2010 [Epub ahead of print].

10.1016/j.phrs.2006.04.003

10.1007/BF03180575

10.1016/j.alcohol.2008.12.005

10.1007/s13539-010-0016-0

10.1002/cncr.11742

10.1634/theoncologist.12-S1-43

Portenoy RK, 1999, Cancer-related fatigue: guidelines for evaluation and management, Oncol, 4, 1, 10.1634/theoncologist.4-1-1

10.1002/(SICI)1097-4652(200003)182:3<339::AID-JCP4>3.0.CO;2-B

Neri B, 1986, Protective effect of L-carnitine on cardiac metabolic damage induced by doxorubicin in vitro, Anticancer Res, 6, 659

10.1016/0006-2952(87)90320-0

10.1016/0006-2952(90)90438-Q

10.1006/bbrc.1996.1095

Visarius TM, 1998, Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats, Drug Metab Dispos, 26, 193

10.1016/j.jpainsymman.2006.09.001

10.1016/j.nut.2007.12.010

10.1152/japplphysiol.90884.2008

10.1038/ajh.2008.271

10.3109/08923979309066930

10.1053/j.jrn.2004.10.002

10.1093/ndt/gfl356

10.1159/000071709

Alesci S, 2003, L-carnitine: A nutritional modulator of glucocorticoid receptor functions, FASEB J, 17, 1553, 10.1096/fj.02-1024fje

Yamashita AS Lira FS Rosa JC Paulino EC Brum PC Negrão CE Dos Santos RV Batista ML Jr Oller do Nascimento C Oyama LM Seelaender M. Depot-specific modulation of adipokine levels in rat adipose tissue by diet-induced obesity: The effect of aerobic training and energy restriction. Cytokine 2010 [Epub ahead of print].

10.1007/s00421-009-1070-1

10.1002/cbf.1540

10.1007/s00441-004-0987-2

10.1097/00024382-199402000-00007

10.1152/ajpendo.90252.2008

von Haehling S Morley JE Coats AJS Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle 2010;1:7–8.